Eli Lilly boss: 'Tariffs are pivotal moment and hard to come back from'
The Chief Executive of Eli Lilly has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst raising billions in tax revenue
Eli Lilly
since
auto-detected in 498 stories
36 days ago
46 days ago
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.
64 days ago
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
found
Telehealth firms Teladoc and LifeMD said they signed an agreement with Eli Lilly's pharmacy partner to offer patients the weight-loss drug, Zepbound.
65 days ago
Amgen starts two critical late-stage trials for weight loss drug MariTide
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
Amgen starts two critical late-stage trials for weight loss drug MariTide
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
77 days ago
'Godzilla' weight loss jab that's even more effective than Ozempic has alarming downside
Unlike other slimming injections, the jab manufactured by US pharmaceutical giant Eli Lilly not only suppresses the appetite but also speeds up the metabolism.
78 days ago
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
3 months ago
S&P 500 posts modest gain, notching third straight winning session
Following a second day of stock market gains, investors looked forward to earnings reports from Eli Lilly and Amazon.
S&P 500 posts modest gain, notching third straight winning session
Following a second day of stock market gains, investors looked forward to earnings reports from Eli Lilly and Amazon.
|← first ← previous page 3 of 4 next → last →|